These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 1031037

  • 1. [The use of an injectable anti-aldosteron agent in the treatment of secondary hyperaldosteronism].
    Tartagni F, Ambrosioni E.
    Boll Soc Ital Cardiol; 1976; 21(4):725-7. PubMed ID: 1031037
    [No Abstract] [Full Text] [Related]

  • 2. [Effectiveness of K canrenoate in the treatment of secondary hyperaldosteronism].
    Tartagni F, Pasetti L, Ambrosioni E, Magnani B.
    G Clin Med; 1979 Mar; 60(3):196-206. PubMed ID: 520727
    [No Abstract] [Full Text] [Related]

  • 3. [Use of an aldosterone antagonist in abdominal surgery].
    Ribero F, Remonda G, Morachioli N, Pugnani M.
    Ann Osp Maria Vittoria Torino; 1982 Mar; 25(1-6):61-70. PubMed ID: 7185311
    [Abstract] [Full Text] [Related]

  • 4. [Therapeutic report on an injectable aldosterone antagonist (K-canrenoate) in states of water-salf retention].
    Coltorti M, Radaeli E, Ciaccio S, Corsini R, Trebbi R.
    Clin Ter; 1976 Feb 15; 76(3):215-34. PubMed ID: 963962
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Potassium canreonate in neurosurgical brain edema].
    Mille T, Rodriguez R, Baena Y.
    Minerva Chir; 1976 Feb 15; 30(13-14):781-9. PubMed ID: 1221307
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Efficacy of canrenoate potassium in hypertensive cardiopathy. Clinical and echocardiographic evaluation].
    Caporicci D, Achilli L.
    Minerva Cardioangiol; 1984 Sep 15; 32(9):581-7. PubMed ID: 6514202
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
    Sarti F, Milandri GL, Piemontese A, Macchia S, Simoni S, Dal Monte PR.
    Minerva Dietol Gastroenterol; 1984 Sep 15; 30(3):273-80. PubMed ID: 6504377
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antihypertensive efficacy and effects on intra and extracellular electrolytes of a canrenoate potassium-butizide combination].
    Costa FV, Borghi C, Mussi A, Ambrosioni E.
    Minerva Cardioangiol; 1988 Oct 15; 36(10):503-7. PubMed ID: 3226562
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.